Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Amanta HealthcareNSE:AMANTA -1.36%14 EBIT per Share is ₹8.92 as of Mar. 2026. GuruFocus rates NSE:AMANTA with a GF Score™ of 14/100. The stock has 3 warning signs investors should review. Among 813 Drug Manufacturers companies, Amanta Healthcare ranks better than 54% on this metric.
Amanta Healthcare's EBIT per Share for the
three
months ended in Mar. 2026 was ₹3.45.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ₹8.92.
During the past 12 months, the average EBIT per Share Growth Rate of Amanta Healthcare was 12.60% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 10.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Amanta Healthcare's EBIT per Share or its related term are showing as below:
NSE:AMANTA'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 4.3 Med: 7.2 Max: 10.1
Current: 10.1
During the past 5 years, the highest 3-Year average EBIT per Share Growth Rate of Amanta Healthcare was 10.10% per year. The lowest was 4.30% per year. And the median was 7.20% per year.
NSE:AMANTA's 3-Year EBIT Growth Rate is ranked better than 54% of 813
companies
in the Drug Manufacturers industry
Industry Median: 7.5
vs NSE:AMANTA: 10.10
Amanta Healthcare (NSE:AMANTA) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Amanta Healthcare EBIT per Share Related Terms
Amanta Healthcare EBIT per Share Historical Data
* Premium members only.
The historical data trend for Amanta Healthcare's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8.92
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amanta Healthcare (NSE:AMANTA) has a EBIT per Share of ₹8.92 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Amanta Healthcare and its competitors. According to the industry distribution chart, Amanta Healthcare ranks #374 out of 813 companies in the Drug Manufacturers industry, placing it in the top 46%.
Is Amanta Healthcare's EBIT per Share too high?
Amanta Healthcare's current EBIT per Share is ₹8.92. Based on the distribution chart, Amanta Healthcare ranks #374 out of 813 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Amanta Healthcare has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Amanta Healthcare's EBIT per Share compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Amanta Healthcare ranks #374 out of 813 companies for EBIT per Share. This puts Amanta Healthcare in the upper half of its industry. The industry median EBIT per Share is 7.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.50, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Amanta Healthcare and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amanta Healthcare's current EBIT per Share is ₹8.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amanta Healthcare stock overvalued right now?
Amanta Healthcare (NSE:AMANTA) has a current EBIT per Share of ₹8.92. The current EBIT per Share is ₹8.92. Amanta Healthcare's overall GF Score™ is 14/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Amanta Healthcare (NSE:AMANTA), the current EBIT per Share is ₹8.92 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Amanta Healthcare Ltd is a pharmaceutical company engaged in developing, manufacturing and marketing a diverse range of sterile liquid products - parenteral products, being packed in plastic container with Aseptic Blow-Fill-Seal and Injection Strech Blow Moulding technology. It manufactures large volume parenterals and small volume parenterals in six therapeutic segments. It also manufactures medical devices. The company manufactures fluid therapy, formulations, diluents, ophthalmic, respiratory care and irrigation solutions in therapeutic segment and products like irrigation, first-aid solution, eye lubricants etc. in medical device segment. It offers wide range of closure systems, such as nipple head, twist-off, leur-lock and screw types and container fill-volume till 1000 ml.
14GF Score
Get the complete analysis for NSE:AMANTA
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AMANTA has been successfully added to your 
